(3 R ,4 S )-3-[4-(4-Fluorophenyl)-4-hydroxypiperidin-1-yl]chroman-4,7-diol: A Conformationally Restricted Analogue of the NR2B Subtype-Selective NMDA Antagonist (1 S ,2 S )-1-(4-Hydroxyphenyl)-2- (4-hydroxy-4-phenylpiperidino)-1-propanol
β Scribed by Butler, Todd W.; Blake, James F.; Bordner, Jon; Butler, Paul; Chenard, Bertrand L.; Collins, Mary A.; DeCosta, Debra; Ducat, Mary J.; Eisenhard, Michael E.; Menniti, Frank S.; Pagnozzi, Martin J.; Sands, Steven B.; Segelstein, Barbara E.; Volberg, Walter; White, W. Frost; Zhao, Dayao
- Book ID
- 127100419
- Publisher
- American Chemical Society
- Year
- 1998
- Tongue
- English
- Weight
- 263 KB
- Volume
- 41
- Category
- Article
- ISSN
- 0022-2623
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Antagonists at the 1A/2B subtype of the NMDA receptor (NR1A/2B) are typically small molecules that consist of a 4-benzyl-or a 4-phenylpiperidine with an Ο-phenylalkyl substituent on the heterocyclic nitrogen. Many of these antagonists, for example ifenprodil (1), incorporate a 4-hydroxy substituent
## Abstract Starting with [^14^C]βDβtyrosine, carbonβ14 labeled JDTic dihydrochloride with specific activity 15βmCi/mol was prepared in 5% radiochemical yield. Separation of the (3__R__)β and (3__S__)βdiastereomers was carried out via the 3βphenylβ2,3,10,10aβtetrahydroβ5Hβimidazo[1,5βb]isoquinolinβ